Geneva, Oct. 15 -- International Clinical Trials Registry received information related to the study (ChiCTR2600133901) titled 'Clinical study of IDH1/2 mutations on glycolysis and therapeutic effect in patients with acute myeloid leukemia' on Oct. 9.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: First Affiliated Hospital of Kunming Medical University
Condition:
Acute myeloid leukemia
Intervention:
IDH1/2 mutation group:N/A
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-10-15
Target Sample Size: IDH1/2 mutation group:10;the IDH wild-type group:10;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=345995
Disclaimer: ...